GGrantIndex
Sort

23,748 grants matching melanoma

A digital intervention to improve skin self-examination among melanoma survivors

$612,975
Sharon L Manne · Rutgers Biomedical And Health Sciences · R01 · FY2025 · CA

Dissecting Phenotype Switching in Early Stage Melanomas

$612,946
Markus Schober · New York University School Of Medicine · R01 · FY2023 · CA

Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model

$612,841
Ryan C Fields · Washington University · R01 · FY2020 · CA

Dissecting the complexity of metastasis with mathematical models and quantitative experiments with in zebrafish

$612,779
Joao Xavier · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA

COVID vaccine-associated allergic reactions

$612,630
Pamela Frischmeyer-Guerrerio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Fast, large area, multiphoton exoscope (FLAME) for improving early detection of melanoma

$611,962
Mihaela Balu · University Of California-Irvine · R01 · FY2024 · CA

ENHANCED DEVELOPMENT OF THE XIPHOPHORUS MODEL SYSTEM

$611,633
Ronald Walter · Texas State University · R24 · FY2011 · RR

Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens

$611,615
William C Hahn · Dana-Farber Cancer Inst · U01 · FY2020 · CA

Moving TIL Therapy Past the Valley of Death

$611,581
John Wilson · Wilson Wolf Manufacturing Corporation · U44 · FY2013 · CA

Cancer Center Support Grant

$611,572
Benjamin G. Neel · New York University School Of Medicine · P30 · FY2015 · CA

VLA-4–targeted 67Cu-LLP2A preconditioning enhances efficacy of T-cell-based adoptive immunotherapy

$611,562
Ravi Bhasker Patel · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA

Development of Organometallic Protein Kinase Inhibitors with Anticancer Activity

$611,248
Eric Meggers · Wistar Institute · P01 · FY2010 · CA

AIM(2)ing at the inflammasome: Impact of MAVS signaling in cocaine-and HIV-1 induced neuroinflammation

$611,217
Irma Cisneros · University Of Texas Med Br Galveston · R01 · FY2022 · DA

AIM(2)ing at the inflammasome: Impact of MAVS signaling in cocaine-and HIV-1 induced neuroinflammation

$611,217
Irma Cisneros · University Of Texas Med Br Galveston · R01 · FY2021 · DA

TARGETING INCREASED POLYAMINE TRANSPORT OF RESISTANT MELANOMAS

$611,214
Lankenau Institute For Medical Research · · FY2016 · Department of Defense

POTENTIATION OF ANTI-TUMOR IMMUNITY BY ONCOLYTIC VIRUS IN SITU VACCINATION

$611,086
Dmitriy Zamarin · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA

Optimized ex vivo expansion of anti-tumor Th1 and Tc1 for adoptive immunotherapy

$611,011
Mary L. Disis · University Of Washington · R01 · FY2012 · CA

Fiber bundle-based divided-pupil confocal endoscope

$610,926
Milind Rajadhyaksha · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA

Infections, immunity, and inflammation in cancer

$610,884
Eric A Engels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA

Epigenetic Regulation of Skin Regeneration

$610,874
Christine Guo Lian · Brigham And Women'S Hospital · P01 · FY2024 · AG

Epigenetic Regulation of Skin Regeneration

$610,872
Christine Guo Lian · Brigham And Women'S Hospital · P01 · FY2023 · AG

Quantitative assessment of pre-metastatic immune subversion as a risk factor for melanoma relapse

$610,829
Svetomir Nenad Markovic · Mayo Clinic Rochester · R01 · FY2023 · CA

Molecular Mechanism of Action of Phorbol Ester

$610,815
Peter Blumberg · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Role of DeltaNp63 alpha and TIP60 in SCC progression and chemoresistance

$610,770
Madhavi P Kadakia · Wright State University · R01 · FY2025 · CA

Correlative biomarkers of IL-6 blockade combined with checkpoint inhibition

$610,766
Jeffrey S Weber · New York University School Of Medicine · R01 · FY2020 · CA